Analyst rating accuracy & track record
Jason Gerberry is an equity research analyst at B of A Securities. Bullish Whales has scored 21 of their stock calls across 12 companies. Their picks beat their sector 46% of the time over the next 12 months, and their price targets were reached 48% of the time within a year.
Track record
Bullish Whales has scored 21 of Jason Gerberry's stock calls across 12 companies, dating back to 2021. Their rated stocks beat their own sector 46% of the time over the next 12 months. On a typical call, a Gerberry pick returned −1.3% more than its sector over the following year.
Of the scored calls, 13 were bullish (Buy) and 8 were bearish (Sell). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.
Coverage & ratings
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 TEVATeva Pharma Industries Ltd ADR | Buy | $22.00 | May 2025 | +101.0% | Hit |
 PCVXVaxcyte Inc | Buy | $137.00 | Apr 2025 | +69.4% | Miss |
 IMVTImmunovant Inc | Buy | $33.00 | Mar 2025 | +16.1% | Miss |
| TEVATeva Pharma Industries Ltd ADR | Buy | $20.00 | Mar 2025 | +98.1% | Hit |
 VTRSViatris Inc | Sell | $10.00 | Feb 2025 | −69.0% | Hit |
| IMVTImmunovant Inc | Buy | $45.00 | Jan 2025 | −3.9% | Miss |
 CPRXCatalyst Pharmaceuticals Inc | Buy | $30.00 | Jan 2025 | −11.0% | Miss |
 BHVNBiohaven Ltd. | Buy | $62.00 | Sep 2024 | −63.1% | Miss |
| PCVXVaxcyte Inc | Buy | $140.00 | Sep 2024 | −61.8% | Miss |
 GLPGGalapagos NV ADR | Sell | $31.00 | Apr 2024 | +23.0% | Hit |
| GLPGGalapagos NV ADR | Sell | $31.00 | Mar 2024 | +21.9% | Hit |
 LYRALyra Therapeutics Inc | Buy | $11.00 | Mar 2024 | −98.7% | Miss |
| CPRXCatalyst Pharmaceuticals Inc | Buy | $23.00 | Mar 2024 | +31.6% | Hit |
| VTRSViatris Inc | Sell | $9.00 | Oct 2023 | −13.6% | Hit |
| LYRALyra Therapeutics Inc | Buy | $15.00 | Sep 2023 | −113.1% | Miss |
 OCSOculis Holding AG Ordinary shares | Buy | $24.00 | Aug 2023 | −27.1% | Miss |
| OCSOculis Holding AG Ordinary shares | Buy | $22.00 | Jun 2023 | −15.9% | Miss |
 TVRDTvardi Therapeutics, Inc. | Sell | $4.00 | May 2023 | +95.3% | Hit |
| TVRDTvardi Therapeutics, Inc. | Sell | $6.00 | Mar 2023 | +102.8% | Hit |
 OGNOrganon & Co | Sell | $25.00 | Oct 2022 | +31.6% | Hit |
 BYSIBeyondSpring Inc | Sell | $5.00 | Dec 2021 | +94.6% | Hit |
Jason Gerberry: analyst track record FAQ
Is Jason Gerberry a good stock analyst?
Yes, by track record. Jason Gerberry ranks number 104 of 347 of the analysts Bullish Whales scores, with a BW Score of 46 out of 100. Past results do not guarantee future ones.
What is Jason Gerberry's win rate?
Jason Gerberry's win rate is 46%. Across 21 scored calls, their rated stocks beat their sector 46% of the time over the next 12 months. On a typical call they returned −1.3% more than the sector.
What stocks and sectors does Jason Gerberry cover?
Jason Gerberry covers 12 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.
Are Jason Gerberry's price targets accurate?
Jason Gerberry's price targets are reached within 12 months 48% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.
How accurate are Wall Street analyst price targets?
Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.
Should I follow Jason Gerberry's stock ratings?
Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.
How does Bullish Whales score analyst accuracy?
Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.
How does Jason Gerberry rank among Wall Street analysts?
Jason Gerberry ranks number 104 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.